About
Corimmun GmbH develops cell-based therapies aimed at restoring immune system function and regenerating hematopoietic systems in patients with immune deficiencies and cancer.
Explore Corimmun GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.